Safe and effective in vivo delivery of DNA and RNA using proteolipid vehicles

Genetic medicines show promise for treating various diseases, yet clinical success has been limited by tolerability, scalability, and immunogenicity issues of current delivery platforms. To overcome these, we developed a proteolipid vehicle (PLV) by combining features from viral and non-viral approaches. PLVs incorporate fusion-associated small transmembrane (FAST) proteins isolated from fusogenic orthoreoviruses into a well-tolerated lipid formulation, using scalable microfluidic mixing. Screening a FAST protein library, we identified a chimeric FAST protein with enhanced membrane fusion activity that improved gene expression from an optimized lipid formulation. Systemically administered FAST-PLVs showed broad biodistribution and effective mRNA and DNA delivery in mouse and non-human primate models. FAST-PLVs show low immunogenicity and maintain activity upon repeat dosing. Systemic administration of follistatin DNA gene therapy with FAST-PLVs raised circulating follistatin levels and significantly increased muscle mass and grip strength. These results demonstrate the promising potential of FAST-PLVs for redosable gene therapies and genetic medicines.

Authors

Institutions

Publication Details

Journal
Cell
Published
2024-09-01
DOI
https://doi.org/10.1016/j.cell.2024.07.023
Citations
57
Primary Topic
RNA Interference and Gene Delivery
Type
article
Field-Weighted Citation Impact
13.33
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Safe and effective in vivo delivery of DNA and RNA using proteolipid vehicles

Duncan S. MacKenzie, Henry David Mogollón García, Arun Raturi, Desmond Pink et al.
57 citations
Cell
RNA Interference and Gene Delivery
13.33
article

Safe and effective in vivo delivery of DNA and RNA using proteolipid vehicles

Duncan S. MacKenzie, Henry David Mogollón García, Arun Raturi, Desmond Pink, Maryam Hejazi, Brendan Todd, Luis Carlos Morales, Liliya Grin, Prakash Bhandari, Amirali B. Bukhari, Jennifer Gyoba, Roy Duncan, Jailal Ablack, Héctor Vega, Fahed Elian, Deborah Sosnowski, Somnath Gupta, Suellen Lamb, Eileen K. Clancy, Perrin H. Beatty, Nichole McMullen, Matthew Scholz, Bijal Rawal, Chandra H. McAllister, Ping Wee, John D. Lewis, Douglas W. Brown, Jitendra Kumar, Manoj Parmar, Rodrigo Quevedo, Angela Delmage, Maria Paola Solis Ares, Natasha Govindasamy, Natasha Rana
article en
57 citations

Abstract

Genetic medicines show promise for treating various diseases, yet clinical success has been limited by tolerability, scalability, and immunogenicity issues of current delivery platforms. To overcome these, we developed a proteolipid vehicle (PLV) by combining features from viral and non-viral approaches. PLVs incorporate fusion-associated small transmembrane (FAST) proteins isolated from fusogenic orthoreoviruses into a well-tolerated lipid formulation, using scalable microfluidic mixing. Screening a FAST protein library, we identified a chimeric FAST protein with enhanced membrane fusion activity that improved gene expression from an optimized lipid formulation. Systemically administered FAST-PLVs showed broad biodistribution and effective mRNA and DNA delivery in mouse and non-human primate models. FAST-PLVs show low immunogenicity and maintain activity upon repeat dosing. Systemic administration of follistatin DNA gene therapy with FAST-PLVs raised circulating follistatin levels and significantly increased muscle mass and grip strength. These results demonstrate the promising potential of FAST-PLVs for redosable gene therapies and genetic medicines.

CellVol. 187(19)
Dalhousie University (CA), University of Alberta (CA), Adaptive Biotechnologies (United States) (US)
Openalex Percentile: Top 1%
RNA Interference and Gene Delivery
13.33
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.